FCRLB-mediated dual control of tumor metabolism and macrophage polarization promotes lung cancer malignancy
Open Access
- 16 February 2026
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Abstract
Immunotherapy has improved outcomes in non-small cell lung cancer (NSCLC), yet primary and acquired resistance remain common. Pinpointing regulators of tumKeywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (No. 82203608)
- National Natural Science Foundation of China (No. 32300753)
- Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China (LHDMY23H160002)
- Natural Science Foundation of Zhejiang Province (LQN25H160012)
This publication has 47 references indexed in Scilit:
- 7,8-Dihydroxyflavone protects acetaminophen induced liver injury through activating PI3K/Akt/NRF2/GPX4 mediated ferroptosis suppressionFree Radical Biology and Medicine, 2025
- Mutations in MLL3 promote breast cancer progression via HIF1α-dependent intratumoral recruitment and differentiation of regulatory T cellsImmunity, 2025
- OPG promotes lung metastasis by reducing CXCL10 production of monocyte-derived macrophages and decreasing NK cell recruitmentEBioMedicine, 2024
- Advances and challenges in the treatment of lung cancerBiomedicine & Pharmacotherapy, 2023
- SLC7A5 is a lung adenocarcinoma-specific prognostic biomarker and participates in forming immunosuppressive tumor microenvironmentHeliyon, 2022
- Integrated microbiome, metabolome, and proteome analysis identifies a novel interplay among commensal bacteria, metabolites and candidate targets in non‐small cell lung cancerClinical and Translational Medicine, 2022
- Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastomaCancer Letters, 2022
- Aryl Hydrocarbon Receptor Controls Monocyte Differentiation into Dendritic Cells versus MacrophagesImmunity, 2017
- Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progressionCancer Letters, 2017
- Defining the immunological phenotype of Fc receptor-like B (FCRLB) deficient mice: Confounding role of the inhibitory FcγRIIbCellular Immunology, 2010